Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine-assisted CBT for methamphetamine use disorder
ACTRN12624000895583Phase 4Recruiting
- Sponsor
- St Vincent's Hospital Sydney
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ketamine in methamphetamine use disorder (MUD) and stimulant use disorder (SUD), sponsored by St Vincent's Hospital Sydney. Primary endpoints: Safety and Feasibility. Started Apr 2025; status: recruiting.
02
Drugs
ketamine
03
Conditions
methamphetamine use disorder (MUD)stimulant use disorder (SUD)
Beyond the preview
Go deeper on ACTRN12624000895583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000895583.